Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Income Statement [Abstract]
Revenues
Cost and expenses:
Research and development	423,277	7,136,679	445,512	9,676,247
General and administrative	919,488	1,367,169	2,177,848	4,009,918
Asset impairment loss	402,746		402,746
Total operating expenses	1,745,511	8,503,848	3,026,106	13,686,165
Loss from operations	(1,745,511)	(8,503,848)	(3,026,106)	(13,686,165)
Other income (expense):
Interest income (expense)	4,866	49,536	(19,945)	45,187
Change in fair value of contingent consideration and derivative financial instruments	698,073	4,529,100	(4,102,408)	6,459,752
Inducement expense				(2,567,044)
Loss before income taxes	(1,042,572)	(3,925,212)	(7,148,459)	(9,748,270)
Income tax benefit				2,969,252
Net loss	$ (1,042,572)	$ (3,925,212)	$ (7,148,459)	$ (6,779,018)
Weighted-average common shares outstanding:
Weighted-average common shares outstanding basic	11,328,122	115,983	7,137,017	108,728
Weighted-average common shares outstanding diluted	11,328,122	115,983	7,137,017	108,728
Net loss per common share: (see Note 10)
Net loss per common share basic	$ (0.09)	$ (34.00)	$ (1.00)	$ (62.50)
Net loss per common share diluted	$ (0.09)	$ (34.00)	$ (1.00)	$ (62.50)